GSK PLC's ticker is and the CUSIP is 37733W204. A total of 880 filers reported holding GSK PLC in Q4 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $484,138 | -12.2% | 12,575 | -2.3% | 0.11% | -14.8% |
| Q1 2024 | $551,608 | +16.2% | 12,867 | +0.5% | 0.13% | +3.2% |
| Q4 2023 | $474,590 | +2.7% | 12,806 | +0.5% | 0.12% | -9.5% |
| Q3 2023 | $461,934 | -10.9% | 12,743 | -12.4% | 0.14% | -25.1% |
| Q2 2023 | $518,384 | -4.1% | 14,545 | -4.3% | 0.18% | -9.4% |
| Q1 2023 | $540,780 | +79.1% | 15,199 | +76.9% | 0.20% | +75.7% |
| Q4 2022 | $301,958 | – | 8,593 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 12,340,190 | $457,759 | 41.36% |
| Eversept Partners, LP | 2,972,954 | $110,177,675 | 9.68% |
| Soleus Capital Management, L.P. | 1,278,540 | $47,382,692 | 5.26% |
| CANTOR FITZGERALD, L. P. | 638,657 | $23,668,628 | 4.86% |
| Sio Capital Management, LLC | 571,391 | $21,175,750 | 4.82% |
| Callodine Capital Management, LP | 450,000 | $16,677,000 | 4.39% |
| EQUITY INVESTMENT CORP | 3,243,259 | $120,195,186 | 3.38% |
| Clean Yield Group | 213,431 | $7,909,753 | 3.33% |
| Robinson Value Management, Ltd. | 128,079 | $4,746,608 | 3.12% |
| Hillman Capital Management, Inc. | 233,386 | $8,649,285 | 2.99% |